|
|
|
|
|
Legal status
Patent lapsed (non-payment of fees)
| (51) | INT.CL. | A61K 9/20 | (2006.01) |
| A61K 9/28 | (2006.01) | ||
| A61K 31/4196 | (2006.01) | ||
| A61P 39/04 | (2006.01) |
| (11) | Number of the document | 3124018 |
| (13) | Kind of document | T |
| (96) | European patent application number | 16188627.0 |
| Date of filing the European patent application | 2014-03-06 | |
| (97) | Date of publication of the European application | 2017-02-01 |
| (45) | Date of publication and mention of the grant of the patent | 2017-12-20 |
| (46) | Date of publication of the claims translation | 2018-03-12 |
| (30) | Number | Date | Country code |
| 201361774893 P | 2013-03-08 | US | |
| 201361824435 P | 2013-05-17 | US |
| (72) |
GHOSH, Indrajit, US
ZHANG, Jia-Ai, US
|
| (73) |
NOVARTIS AG,
Lichtstrasse 35, 4056 Basel,
CH
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Deferasirokso peroraliniai preparatai |
| ORAL FORMULATIONS OF DEFERASIROX |
| Payment date | Validity (years) | Amount | |
| 2023-02-23 | 10 | 231.00 EUR |
| Patent lapsed (non-payment of fees) | ||
| Invalidation date | 2024-03-06 |